alzheimer-s

Documents about alzheimer-s

• Obesity-driven phosphatidylethanolamine dysregulation impairs neuroimmune crosstalk and accelerates Alzheimer's pathogenesis.#174613NCBI PubMed Central
• Partially-shared Imaging Regression on Integrating Heterogeneous Brain-Cognition Associations across Alzheimer's Diagnoses#183248arXiv (OAI)
• Effect of Insulin Sensitizer Metformin on AD Biomarkers#208393ClinicalTrials.gov
• Artificial intelligence for detection and staging of Alzheimer's disease using retinal images.#218780NCBI PubMed Central
• Predicting categorical and continuous Alzheimer's disease outcomes from a single MRI scan.#218805NCBI PubMed Central
• Dietary Choline Intake and Risk of Alzheimer's Dementia in Older Adults.#236310NCBI PubMed Central
• Influence of an AQP4 haplotype and sleep duration on early Alzheimer's disease.#265292NCBI PubMed Central
• Tunable acoustic rotation for deep biophysical phenotyping of preclinical Alzheimer's disease.#266942NCBI PubMed Central
• Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease#273297Europe PMC
• Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.#284882NCBI PubMed Central
• Direct RNA Sequencing reveals epitranscriptomic regulation of brain cells and Alzheimer's Disease pathology#287239bioRxiv / medRxiv
• Adaptive neighborhood aggregation graph neural network for early diagnosis of Alzheimer's disease.#297188NCBI PubMed Central
• Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies.#312379NCBI PubMed Central
• The Utility of Speech and Language Analytics for Screening Alzheimer's Disease.#315801NCBI PubMed Central
• Development of a serum-based microRNA panel for Alzheimer's disease diagnosis.#334740NCBI PubMed Central
• Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.#340273NCBI PubMed Central
• National Alzheimer's Coordinating Center cerebral neuropathology and cognitive function in atrial fibrillation.#362116NCBI PubMed Central
• Lymphoid-like Suppressive Microglia in Alzheimer's Disease: A New Neuroimmune Regulatory Axis?#367991NCBI PubMed Central
• Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.#371445NCBI PubMed Central
• Abnormal hippocampo-cortical theta-gamma phase-amplitude coupling in Alzheimer’s disease#422492Europe PMC
• Motor performance and its association with Alzheimer's-related biomarkers: a systematic review.#422840NCBI PubMed Central
• Generalized Multilevel Multisource Functional Regression With an Application to Alzheimer's Disease.#431006NCBI PubMed Central
• Advancements in non-pharmaceutical interventions for Alzheimer's disease management: an update review.#433762NCBI PubMed Central
• Thalamic volume alterations mediate glymphatic function and cognitive dysfunction in Alzheimer's disease.#436861NCBI PubMed Central
• Ferroptosis-related biomarkers for diagnosis and mechanistic insights into Alzheimer's disease.#437026NCBI PubMed Central
• Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.#438938NCBI PubMed Central
• Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.#442868NCBI PubMed Central
• Mental health and gut-brain crosstalk: implications for depression and Alzheimer's disease.#455133NCBI PubMed Central
• What Do Persistent Misclassifications Tell Us About Alzheimer's Disease Detection using Structural MRI?#463564bioRxiv / medRxiv
• Plant-mediated green nanoparticles: combining nanometal and biometabolite potential for Alzheimer's treatment.#472372NCBI PubMed Central
• Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease#475680Europe PMC
• Functional assessment improves discrimination of clinical and biomarker-defined Alzheimer’s disease#475740Europe PMC
• Genetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer's disease progression#478595Europe PMC
• Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.#479178NCBI PubMed Central
• Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer's disease.#480783NCBI PubMed Central
• Indices of Arterial Stiffness and the Alzheimer s Disease Biomarker, p-tau217, in Non-Demented Midlife Women#357806ScholarBank@NUS
• A comprehensive assessment of cholinesterase inhibitors for the treatment of Alzheimer’s disease based on drug selection recommendations for Chinese Medical Institutions#436111Figshare
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11947DataCite
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11948DataCite
• Methodological approaches to account for assay changes in longitudinal biomarker analysis: insights from Alzheimer’s blood biomarkers in the MEMENTO cohort#280350HAL (France)
• Multicenter study on the effect of CPAP on cognitive function in patients with mild cognitive impairment and Alzheimer’s disease with OSA (DemCPAP): presentation of the protocol and preliminary data#482805IRIS
• Amyloid Plaques Ameliorate Memory Deficits and Hippocampal Neuron Loss in an Aβ4-42-Driven Alzheimer's Disease Mouse Model.#193322NCBI PubMed Central
• Acceptability of Technologies to Support Early Dementia Detection: Qualitative Study With the Boston University Alzheimer's Disease Center Cohort.#244213NCBI PubMed Central
• Enhancing Early Detection of Alzheimer's Disease: An Ensemble Model for Multi-Domain Cognitive Assessment Using Voice and Video.#317593NCBI PubMed Central
• Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning#337055bioRxiv / medRxiv
• TriFusion-ADFormer: a deep learning framework for early Alzheimer's disease detection using MRI and cognitive metrics.#446122NCBI PubMed Central
• Alzheimer's Biomarkers and Visuospatial Cognition in Parkinson's Disease: Modification by α-Synuclein and Mediation of Age Effects.#458574NCBI PubMed Central
• Magnetoreceptive CRY/MagR complexes: linking circadian redox signalling to protein aggregation in Alzheimer's and Parkinson's disease.#480939NCBI PubMed Central
• Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease#185646IRIS
• Theoretical impact of a mobile team dedicated to patients with Alzheimer’s disease and related dementias on medication exposure in community-dwelling older patients (MEMORIAS study)#374428HAL (France)